Aier Eye Hospital Group (300015) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Aier Eye Hospital Group (300015) has a cash flow conversion efficiency ratio of 0.071x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥1.69 Billion ≈ $246.85 Million USD) by net assets (CN¥23.82 Billion ≈ $3.49 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Aier Eye Hospital Group - Cash Flow Conversion Efficiency Trend (2006–2024)
This chart illustrates how Aier Eye Hospital Group's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Aier Eye Hospital Group for a breakdown of total debt and financial obligations.
Aier Eye Hospital Group Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Aier Eye Hospital Group ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Grupo Bimbo S.A.B. de C.V
MX:BIMBOA
|
0.088x |
|
Origin Energy Ltd
AU:ORG
|
0.113x |
|
CoStar Group Inc
NASDAQ:CSGP
|
0.008x |
|
Elia Group SA/NV
BR:ELI
|
0.140x |
|
Dick’s Sporting Goods Inc
NYSE:DKS
|
0.204x |
|
PTT Exploration and Production Public Company Limited
F:NVAL
|
0.080x |
|
Clean Harbors Inc
NYSE:CLH
|
0.109x |
|
Li Auto Inc
NASDAQ:LI
|
-0.101x |
Annual Cash Flow Conversion Efficiency for Aier Eye Hospital Group (2006–2024)
The table below shows the annual cash flow conversion efficiency of Aier Eye Hospital Group from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Aier Eye Hospital Group worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥21.81 Billion ≈ $3.19 Billion |
CN¥4.88 Billion ≈ $714.34 Million |
0.224x | -23.68% |
| 2023-12-31 | CN¥20.02 Billion ≈ $2.93 Billion |
CN¥5.87 Billion ≈ $859.24 Million |
0.293x | +15.03% |
| 2022-12-31 | CN¥17.62 Billion ≈ $2.58 Billion |
CN¥4.49 Billion ≈ $657.13 Million |
0.255x | -23.70% |
| 2021-12-31 | CN¥12.22 Billion ≈ $1.79 Billion |
CN¥4.08 Billion ≈ $597.63 Million |
0.334x | +6.44% |
| 2020-12-31 | CN¥10.65 Billion ≈ $1.56 Billion |
CN¥3.34 Billion ≈ $489.28 Million |
0.314x | +6.06% |
| 2019-12-31 | CN¥7.02 Billion ≈ $1.03 Billion |
CN¥2.08 Billion ≈ $304.14 Million |
0.296x | +26.20% |
| 2018-12-31 | CN¥5.97 Billion ≈ $873.46 Million |
CN¥1.40 Billion ≈ $204.85 Million |
0.235x | -3.54% |
| 2017-12-31 | CN¥5.47 Billion ≈ $800.73 Million |
CN¥1.33 Billion ≈ $194.68 Million |
0.243x | +15.57% |
| 2016-12-31 | CN¥3.21 Billion ≈ $469.58 Million |
CN¥675.10 Million ≈ $98.79 Million |
0.210x | +0.69% |
| 2015-12-31 | CN¥2.50 Billion ≈ $365.71 Million |
CN¥522.17 Million ≈ $76.41 Million |
0.209x | -5.07% |
| 2014-12-31 | CN¥2.06 Billion ≈ $301.63 Million |
CN¥453.68 Million ≈ $66.39 Million |
0.220x | -7.26% |
| 2013-12-31 | CN¥1.74 Billion ≈ $254.44 Million |
CN¥412.65 Million ≈ $60.38 Million |
0.237x | +23.36% |
| 2012-12-31 | CN¥1.57 Billion ≈ $229.58 Million |
CN¥301.82 Million ≈ $44.17 Million |
0.192x | +5.75% |
| 2011-12-31 | CN¥1.41 Billion ≈ $206.81 Million |
CN¥257.11 Million ≈ $37.62 Million |
0.182x | -0.79% |
| 2010-12-31 | CN¥1.31 Billion ≈ $191.49 Million |
CN¥239.97 Million ≈ $35.11 Million |
0.183x | +33.78% |
| 2009-12-31 | CN¥1.23 Billion ≈ $180.56 Million |
CN¥169.14 Million ≈ $24.75 Million |
0.137x | -70.36% |
| 2008-12-31 | CN¥261.99 Million ≈ $38.34 Million |
CN¥121.17 Million ≈ $17.73 Million |
0.463x | +15.81% |
| 2007-12-31 | CN¥230.83 Million ≈ $33.78 Million |
CN¥92.19 Million ≈ $13.49 Million |
0.399x | +62.31% |
| 2006-12-31 | CN¥149.98 Million ≈ $21.95 Million |
CN¥36.90 Million ≈ $5.40 Million |
0.246x | -- |
About Aier Eye Hospital Group
Aier Eye Hospital Group Co., Ltd. operates as a ophthalmology chain medical company in China, Hong Kong, Europe, the United States, and Southeast Asia. The company offers diagnosis and treatment of various ophthalmic diseases, surgical services, medical optometry, and glasses for fundus diseases, refractive correction, glaucoma, corneal diseases, and cataract. It also provides training course for… Read more